Exploring the use of chronic low-dose oral etoposide in ovarian cancer: Is there a role for this "new drug" in the management of platinum-refractory disease?

Maurie Markman, Thomas Hakes, Bonnie Reichman, Richard Barakat, John Curtin, Walter Jones, John L. Lewis, Stephen Rubin, Lois Almadrones, William Hoskins

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Exploring the use of chronic low-dose oral etoposide in ovarian cancer: Is there a role for this "new drug" in the management of platinum-refractory disease?'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science